PHOENIX NEW MED.ADR 1/48 Cash Flow-to-Debt Ratio
PHOENIX NEW MED.ADR 1/48 cash flow-to-debt ratio. PHOENIX NEW MED.ADR 1/48 (1PX) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of €-2.67 Million could theoretically repay 0% of its total liabilities (€541.47 Million) in one year. Check 1PX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PHOENIX NEW MED.ADR 1/48 (2021–2025)
Cash flow-to-debt ratio of PHOENIX NEW MED.ADR 1/48 from 2021 to 2025. Historical debt coverage capacity for PHOENIX NEW MED.ADR 1/48 across 5 annual periods. Also explore PHOENIX NEW MED.ADR 1/48 (1PX) net asset momentum to track the company's year-over-year net asset growth rate.
PHOENIX NEW MED.ADR 1/48 Cash Flow-to-Debt Ratio by Year (2021–2025)
PHOENIX NEW MED.ADR 1/48 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for PHOENIX NEW MED.ADR 1/48. For the full cash flow conversion analysis, see cash flow conversion of PHOENIX NEW MED.ADR 1/48.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | €-2.67 Million | €541.47 Million | ▲ +93.4% |
| 2024 | -0.07x | €-44.30 Million | €598.52 Million | ▲ +27.6% |
| 2023 | -0.10x | €-60.83 Million | €595.12 Million | ▲ +75.0% |
| 2022 | -0.41x | €-312.41 Million | €765.60 Million | ▼ -190.5% |
| 2021 | -0.14x | €-142.82 Million | €1.02 Billion | — |